{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:06:01Z","timestamp":1789841161298,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kaiser Permanente Division of Research Rapid Analytics Grant","award":["1980"],"award-info":[{"award-number":["1980"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Branch retinal artery occlusion (BRAO) is an acute, vision-threatening condition that often signals underlying systemic vascular disease and the need for urgent vascular risk assessment and mitigation. Although prompt evaluation is critical for accurate diagnosis and early identification of modifiable vascular risk factors, patterns of clinical presentation remain poorly characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included BRAO patients who presented to Kaiser Permanente Northern California (KPNC) within 30 days of symptom onset from 2014 to 2023. Demographic data, symptom timing, healthcare contact, and ophthalmologic evaluation were collected. The type of contact was categorized as eye care provider, call center, emergency department\/urgent care, or other. Delays in presentation were defined as time from symptoms to initial contact and were analyzed across subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 2014 to 2023, 760 patients were diagnosed with acute BRAO. Mean age of the study population was 70.2\u2009\u00b1\u200912.6 years, and 330 (43.4%) were female. Initial contact most commonly occurred with eye care providers (370; 48.7%), followed by call centers (251; 33.0%), emergency\/urgent care (73; 9.6%), and other providers (66; 8.7%). Only 219 (28.8%) presented within 1\u00a0day of symptom onset, while 97 (12.8%) presented after 8 days. The majority (541; 71.2%) were not evaluated by an eye care provider until &gt;\u200924\u00a0h after symptom onset. Among the 153 (20.1%) with known time of symptom onset, median delay to any healthcare contact was 4.0\u00a0h. 80 (52.3%) patients presented within 4.5\u00a0h, but just 5 (6.3%) were seen by an eye care provider within that window.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In a large, multi-center, community population, delays in BRAO care were common. Although no Level 1 evidence currently exists to support BRAO treatment, success of future therapies will likely require early administration. Prompt evaluation is also critical to enable risk assessment and mitigation. Most patients in this cohort presented in a delayed fashion, underscoring the need for public education and workflow improvements to support earlier recognition and care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-026-00815-4","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:35:39Z","timestamp":1771670139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Branch retinal artery occlusion time to presentation and diagnosis: a retrospective review"],"prefix":"10.1186","volume":"12","author":[{"given":"Hannah","family":"El-Sabrout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronak","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubrey L.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Sax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubarika","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tova","family":"Mannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Dokey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin A.","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"key":"815_CR1","doi-asserted-by":"publisher","unstructured":"Hayreh S, Podhajsky P, Zimmerman M. Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology. 2009;116(10). https:\/\/doi.org\/10.1016\/j.ophtha.2009.03.006.","DOI":"10.1016\/j.ophtha.2009.03.006"},{"key":"815_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.04.001","volume":"41","author":"SS Hayreh","year":"2014","unstructured":"Hayreh SS. Ocular vascular occlusive disorders: natural history of visual outcome. Prog Retin Eye Res. 2014;41:1\u201325. https:\/\/doi.org\/10.1016\/j.preteyeres.2014.04.001.","journal-title":"Prog Retin Eye Res"},{"key":"815_CR3","first-page":"9","volume":"271","author":"K Hondeghem","year":"1999","unstructured":"Hondeghem K, Blanckaert M, Blanckaert J. Branch retinal artery occlusion in systemic diseases: a case report. Bull Soc Belge Ophtalmol. 1999;271:9\u201315.","journal-title":"Bull Soc Belge Ophtalmol"},{"issue":"7","key":"815_CR4","doi-asserted-by":"publisher","first-page":"e8994","DOI":"10.7759\/cureus.8994","volume":"12","author":"P Iqbal","year":"2020","unstructured":"Iqbal P, Shams A, Ali M, Muthanna B, Hussain T. Rare association of patent foramen ovale and atrial septal aneurysm leading to branch retinal artery occlusion in a young healthy man. Cureus. 2020;12(7):e8994. https:\/\/doi.org\/10.7759\/cureus.8994.","journal-title":"Cureus"},{"issue":"10","key":"815_CR5","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","volume":"72","author":"M Schrag","year":"2015","unstructured":"Schrag M, Youn T, Schindler J, Kirshner H, Greer D. Intravenous fibrinolytic therapy in central retinal artery occlusion: A Patient-Level Meta-analysis. JAMA Neurol. 2015;72(10):1148\u201354. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1578.","journal-title":"JAMA Neurol"},{"issue":"4","key":"815_CR6","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41433-021-01546-6","volume":"36","author":"D Scoles","year":"2022","unstructured":"Scoles D, McGeehan B, VanderBeek BL. The association of stroke with central and branch retinal arterial occlusion. Eye Lond Engl. 2022;36(4):835\u201343. https:\/\/doi.org\/10.1038\/s41433-021-01546-6.","journal-title":"Eye Lond Engl"},{"issue":"4","key":"815_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41433-019-0576-y","volume":"34","author":"M Fallico","year":"2020","unstructured":"Fallico M, Lotery AJ, Longo A, et al. Risk of acute stroke in patients with retinal artery occlusion: a systematic review and meta-analysis. Eye Lond Engl. 2020;34(4):683\u20139. https:\/\/doi.org\/10.1038\/s41433-019-0576-y.","journal-title":"Eye Lond Engl"},{"issue":"3","key":"815_CR8","doi-asserted-by":"publisher","first-page":"e010509","DOI":"10.1161\/JAHA.118.010509","volume":"8","author":"MB Avery","year":"2019","unstructured":"Avery MB, Magal I, Kherani A, Mitha AP. Risk of stroke in patients with ocular arterial occlusive disorders: A retrospective Canadian study. J Am Heart Assoc. 2019;8(3):e010509. https:\/\/doi.org\/10.1161\/JAHA.118.010509.","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"815_CR9","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.3390\/jcm10143093","volume":"10","author":"J Roskal-Wa\u0142ek","year":"2021","unstructured":"Roskal-Wa\u0142ek J, Wa\u0142ek P, Biskup M, et al. Central and branch retinal artery Occlusion-Do they harbor the same risk of further ischemic events? J Clin Med. 2021;10(14):3093. https:\/\/doi.org\/10.3390\/jcm10143093.","journal-title":"J Clin Med"},{"key":"815_CR10","doi-asserted-by":"publisher","unstructured":"Gilbert A, Patel A, Sax D, et al. A telemedicine-enabled intravenous thrombolytic treatment pathway for patients with hyperacute non-arteritic central retinal artery occlusion. Am J Ophthalmol Case Rep. 2024;36. https:\/\/doi.org\/10.1016\/j.ajoc.2024.102204.","DOI":"10.1016\/j.ajoc.2024.102204"},{"issue":"6","key":"815_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.oret.2023.01.005","volume":"7","author":"R Shah","year":"2023","unstructured":"Shah R, Gilbert A, Melles R, et al. Central retinal artery occlusion: time to presentation and diagnosis. Ophthalmol Retina. 2023;7(6):527\u201331. https:\/\/doi.org\/10.1016\/j.oret.2023.01.005.","journal-title":"Ophthalmol Retina"},{"key":"815_CR12","doi-asserted-by":"publisher","unstructured":"Noble J, Weizblit N, Baerlocher M, Eng K. Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review. Br J Ophthalmol. 2008;92(5). https:\/\/doi.org\/10.1136\/bjo.2007.133488.","DOI":"10.1136\/bjo.2007.133488"},{"issue":"13","key":"815_CR13","doi-asserted-by":"publisher","first-page":"e1364","DOI":"10.1212\/WNL.0000000000207445","volume":"101","author":"DW Kang","year":"2023","unstructured":"Kang DW, Jung KH, Yang W, et al. Presence of embolic source and outcome in central retinal artery occlusion. Neurology. 2023;101(13):e1364\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000207445.","journal-title":"Neurology"},{"issue":"1","key":"815_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.18700\/jnc.240004","volume":"17","author":"SJ Bang","year":"2024","unstructured":"Bang SJ, Yang JE, Park SK, Park H, Sohn SI, Hong JH. Favorable outcome after intra-arterial thrombolysis in a patient with branch retinal artery occlusion: a case report. J Neurocritical Care. 2024;17(1):24\u20138. https:\/\/doi.org\/10.18700\/jnc.240004.","journal-title":"J Neurocritical Care"},{"issue":"6","key":"815_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/01658107.2025.2507770","volume":"49","author":"S Shahjouei","year":"2025","unstructured":"Shahjouei S, Basarvad Shahripour R, Dumitrascu OM. Thrombolysis in branch retinal artery occlusion: A systematic review. Neuro-Ophthalmol. 2025;49(6):439\u201347. https:\/\/doi.org\/10.1080\/01658107.2025.2507770.","journal-title":"Neuro-Ophthalmol"},{"key":"815_CR16","doi-asserted-by":"publisher","unstructured":"Anshu PK, Thomas J. Intravenous thrombolysis as vision saving therapy in case of acute onset BRAO. J Neurol Sci. 2023;455. https:\/\/doi.org\/10.1016\/j.jns.2023.122086.","DOI":"10.1016\/j.jns.2023.122086"},{"issue":"Suppl1","key":"815_CR17","doi-asserted-by":"publisher","first-page":"AWP8","DOI":"10.1161\/str.55.suppl_1.WP8","volume":"55","author":"S Shahjouei","year":"2024","unstructured":"Shahjouei S, Bavarsad R, Dumitrascu OM. Abstract WP8: to report the visual outcome and safety profile in patients with branch retinal artery occlusion (BRAO) that received intravenous (IV) and Intra-Arterial (IA) thrombolysis. Stroke. 2024;55(Suppl1):AWP8\u20138. https:\/\/doi.org\/10.1161\/str.55.suppl_1.WP8.","journal-title":"Stroke"},{"issue":"6","key":"815_CR18","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000366","volume":"52","author":"B Mac Grory","year":"2021","unstructured":"Mac Grory B, Schrag M, Biousse V, et al. Management of central retinal artery occlusion: A scientific statement from the American heart association. Stroke. 2021;52(6):e282\u201394. https:\/\/doi.org\/10.1161\/STR.0000000000000366.","journal-title":"Stroke"},{"issue":"10","key":"815_CR19","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.ophtha.2018.03.054","volume":"125","author":"V Biousse","year":"2018","unstructured":"Biousse V, Nahab F, Newman NJ. Management of acute retinal ischemia: follow the Guidelines! Ophthalmology. 2018;125(10):1597\u2013607. https:\/\/doi.org\/10.1016\/j.ophtha.2018.03.054.","journal-title":"Ophthalmology"},{"issue":"4","key":"815_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7812\/TPP\/15-225","volume":"20","author":"N Gordon","year":"2016","unstructured":"Gordon N, Lin T. The Kaiser permanente Northern California adult member health survey. Perm J. 2016;20(4):15\u2013225. https:\/\/doi.org\/10.7812\/TPP\/15-225.","journal-title":"Perm J"},{"issue":"2","key":"815_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.7812\/TPP\/22.172","volume":"27","author":"AC Davis","year":"2023","unstructured":"Davis AC, Voelkel JL, Remmers CL, Adams JL, McGlynn EA. Comparing Kaiser permanente members to the general population: implications for generalizability of research. Perm J. 2023;27(2):87\u201398. https:\/\/doi.org\/10.7812\/TPP\/22.172.","journal-title":"Perm J"},{"key":"815_CR22","doi-asserted-by":"publisher","unstructured":"Steindel SJ. International classification of diseases, 10th edition, clinical modification and procedure coding system: descriptive overview of the next generation HIPAA code sets. J Am Med Inf Assoc JAMIA. 2010;17(3):274\u201382. https:\/\/doi.org\/10.1136\/jamia.2009.001230.","DOI":"10.1136\/jamia.2009.001230"},{"issue":"1","key":"815_CR23","first-page":"53","volume":"113","author":"EA Olson","year":"2016","unstructured":"Olson EA, Lentz K. Central retinal artery occlusion: A literature review and the rationale for hyperbaric oxygen therapy. Mo Med. 2016;113(1):53\u20137.","journal-title":"Mo Med"},{"issue":"7","key":"815_CR24","first-page":"1821","volume":"65","author":"S Desai","year":"2024","unstructured":"Desai S, Sekimitsu S, Han JY, Zebardast N. Racial and socioeconomic disparities in eye care utilization among patients with Vision-Threatening diabetic retinopathy in the all of Us research program. Invest Ophthalmol Vis Sci. 2024;65(7):1821.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"815_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ophtha.2021.09.022","volume":"129","author":"OA Halawa","year":"2022","unstructured":"Halawa OA, Kolli A, Oh G, et al. Racial and socioeconomic differences in eye care utilization among medicare beneficiaries with glaucoma. Ophthalmology. 2022;129(4):397\u2013405. https:\/\/doi.org\/10.1016\/j.ophtha.2021.09.022.","journal-title":"Ophthalmology"},{"issue":"10","key":"815_CR26","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.ophtha.2022.07.010","volume":"129","author":"AR Elam","year":"2022","unstructured":"Elam AR, Tseng VL, Rodriguez TM, Mike EV, Warren AK, Coleman AL. Disparities in vision health and eye care. Ophthalmology. 2022;129(10):e89\u2013113. https:\/\/doi.org\/10.1016\/j.ophtha.2022.07.010.","journal-title":"Ophthalmology"},{"issue":"7","key":"815_CR27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamaophthalmol.2016.1284","volume":"134","author":"R Varma","year":"2016","unstructured":"Varma R, Vajaranant TS, Burkemper B, et al. Visual impairment and blindness in adults in the united states: demographic and geographic variations from 2015 to 2050. JAMA Ophthalmol. 2016;134(7):802\u20139. https:\/\/doi.org\/10.1001\/jamaophthalmol.2016.1284.","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"815_CR28","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1089\/jwh.2007.0402","volume":"17","author":"R Press","year":"2008","unstructured":"Press R, Carrasquillo O, Sciacca RR, Giardina EGV. Racial\/Ethnic disparities in time to Follow-Up after an abnormal mammogram. J Womens Health. 2008;17(6):923\u201330. https:\/\/doi.org\/10.1089\/jwh.2007.0402.","journal-title":"J Womens Health"},{"issue":"6","key":"815_CR29","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.oret.2023.12.007","volume":"8","author":"R Shah","year":"2024","unstructured":"Shah R, Zheng X, Patel AP, Bhatti MT, Gilbert A, Vora RA. Central retinal artery occlusion: visual outcomes from a large Northern California cohort. Ophthalmol Retina. 2024;8(6):566\u201370. https:\/\/doi.org\/10.1016\/j.oret.2023.12.007.","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"815_CR30","doi-asserted-by":"publisher","first-page":"e0177663","DOI":"10.1371\/journal.pone.0177663","volume":"12","author":"JH Hong","year":"2017","unstructured":"Hong JH, Sohn SI, Kwak J, et al. Retinal artery occlusion and associated recurrent vascular risk with underlying etiologies. PLoS ONE. 2017;12(6):e0177663. https:\/\/doi.org\/10.1371\/journal.pone.0177663.","journal-title":"PLoS ONE"},{"issue":"11","key":"815_CR31","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.ophtha.2015.07.018","volume":"122","author":"SJ Park","year":"2015","unstructured":"Park SJ, Choi NK, Yang BR, et al. Risk and risk periods for stroke and acute myocardial infarction in patients with central retinal artery occlusion. Ophthalmology. 2015;122(11):2336\u2013e23432. https:\/\/doi.org\/10.1016\/j.ophtha.2015.07.018.","journal-title":"Ophthalmology"},{"issue":"12","key":"815_CR32","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1001\/jamaophthalmol.2023.4716","volume":"141","author":"KM Wai","year":"2023","unstructured":"Wai KM, Knapp A, Ludwig CA, et al. Risk of Stroke, myocardial Infarction, and death after retinal artery occlusion. JAMA Ophthalmol. 2023;141(12):1110\u20136. https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.4716.","journal-title":"JAMA Ophthalmol"},{"key":"815_CR33","doi-asserted-by":"publisher","first-page":"194187442513172","DOI":"10.1177\/19418744251317260","volume":"29","author":"NU Schwartz","year":"2025","unstructured":"Schwartz NU, Silverman A, Beres S, Moss HE, Kvam K, Galetta K. Inpatient implementation of portable ocular fundus photography among neurology residents. Neurohospitalist Published Online January. 2025;29:19418744251317260. https:\/\/doi.org\/10.1177\/19418744251317260.","journal-title":"Neurohospitalist Published Online January"},{"key":"815_CR34","doi-asserted-by":"publisher","unstructured":"Vasseneix C, Bruce B, Bidot S, Newman N, Biousse V. Nonmydriatic fundus photography in patients with acute vision loss. Telemed J E-Health Off J Am Telemed Assoc. 2019;25(10). https:\/\/doi.org\/10.1089\/tmj.2018.0209.","DOI":"10.1089\/tmj.2018.0209"},{"issue":"6","key":"815_CR35","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ophtha.2023.11.031","volume":"131","author":"GMC Lema","year":"2024","unstructured":"Lema GMC, De Leacy R, Fara MG, et al. A remote consult retinal artery occlusion diagnostic protocol. Ophthalmology. 2024;131(6):724\u201330. https:\/\/doi.org\/10.1016\/j.ophtha.2023.11.031.","journal-title":"Ophthalmology"},{"key":"815_CR36","doi-asserted-by":"publisher","unstructured":"Gungor A, Sarbout I, Gilbert AL, et al. AI-based detection of central retinal artery occlusion within 4.5 hours on standard fundus photographs. medRxiv. Preprint posted online December 23, 2024. https:\/\/doi.org\/10.1101\/2024.12.19.24319390.","DOI":"10.1101\/2024.12.19.24319390"},{"issue":"2","key":"815_CR37","doi-asserted-by":"publisher","first-page":"e0229068","DOI":"10.1371\/journal.pone.0229068","volume":"15","author":"HO Ikeda","year":"2020","unstructured":"Ikeda HO, Muraoka Y, Hata M, et al. Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: an open-label, non-randomized, first-in-humans, phase 1\/2 trial. PLoS ONE. 2020;15(2):e0229068. https:\/\/doi.org\/10.1371\/journal.pone.0229068.","journal-title":"PLoS ONE"},{"issue":"8","key":"815_CR38","doi-asserted-by":"publisher","first-page":"108350","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108350","volume":"34","author":"G Goodwin","year":"2025","unstructured":"Goodwin G, Yelkin H, Mauger M, et al. Various sociodemographic variables on acute and inpatient stroke care. J Stroke Cerebrovasc Dis. 2025;34(8):108350. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2025.108350.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"815_CR39","doi-asserted-by":"publisher","first-page":"e2352927","DOI":"10.1001\/jamanetworkopen.2023.52927","volume":"7","author":"S Man","year":"2024","unstructured":"Man S, Solomon N, Mac Grory B, et al. Trends in stroke thrombolysis care metrics and outcomes by race and Ethnicity, 2003\u20132021. JAMA Netw Open. 2024;7(2):e2352927. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.52927.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"815_CR40","doi-asserted-by":"publisher","first-page":"e000977","DOI":"10.1161\/SVIN.123.000977","volume":"4","author":"A Dagra","year":"2024","unstructured":"Dagra A, Lucke-Wold B, McGrath K, et al. Central retinal artery occlusion: A review of pathophysiological features and management. Stroke Vasc Interv Neurol. 2024;4(1):e000977. https:\/\/doi.org\/10.1161\/SVIN.123.000977.","journal-title":"Stroke Vasc Interv Neurol"},{"issue":"4","key":"815_CR41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jcjo.2022.02.015","volume":"58","author":"MJ Smith","year":"2023","unstructured":"Smith MJ, Benson MD, Tennant M, Jivraj I. Central retinal artery occlusion: a retrospective study of disease presentation, treatment, and outcomes. Can J Ophthalmol. 2023;58(4):318\u201323. https:\/\/doi.org\/10.1016\/j.jcjo.2022.02.015.","journal-title":"Can J Ophthalmol"},{"key":"815_CR42","unstructured":"Rodriguez A, B.E. F.A.S. T. can help spot a stroke | Health Focus SA. University Health. 2025, May 28. Avaiable from: https:\/\/www.universityhealth.com\/blog\/be-f-a-s-t-to-spot-a-stroke. Accessed June 5, 2025."},{"key":"815_CR43","unstructured":"Kleindorfer D, Miller R, Moomaw C, et al. Designing a Message for Public Education Regarding Stroke | Stroke. Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/strokeaha.107.484329. Accessed June 5, 2025."},{"issue":"2","key":"815_CR44","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1525-1497.2005.40136.x","volume":"20","author":"L Shi","year":"2005","unstructured":"Shi L, Stevens GD. Vulnerability and unmet health care needs. J Gen Intern Med. 2005;20(2):148\u201354. https:\/\/doi.org\/10.1111\/j.1525-1497.2005.40136.x.","journal-title":"J Gen Intern Med"},{"key":"815_CR45","doi-asserted-by":"publisher","unstructured":"Cruz-Flores S, Rabinstein A, Biller J, et al. Racial-ethnic disparities in stroke care: the American experience. Stroke. 2011;42(7). https:\/\/doi.org\/10.1161\/STR.0b013e3182213e2.","DOI":"10.1161\/STR.0b013e3182213e2"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00815-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00815-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00815-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:37:43Z","timestamp":1781635063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00815-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00815-4","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board at Kaiser Permanente Northern California Region (IRB 1851192-6) and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RV reports relationships that are not relevant to the manuscript herein: Genentech (consultant, advisory board), Regeneron (advisory board, speaker), Astellas Pharma (consultant, speaker), Outlook Therapeutics (consultant, advisory board), and EyePoint Pharmaceuticals (consultant, advisory board).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}